InvestorsHub Logo
Followers 0
Posts 12
Boards Moderated 0
Alias Born 10/30/2015

Re: None

Wednesday, 11/02/2016 9:02:04 AM

Wednesday, November 02, 2016 9:02:04 AM

Post# of 592
Unique J-code for Bendeka

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) and Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) announced today that the Centers for Medicare & Medicaid Services (CMS) has established a unique, product-specific billing code, or J-code (J9034), for BENDEKA® (bendamustine hydrochloride) Injection. The J-code will become effective on January 1, 2017.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EGRX News